Boston Scientific, St. Jude, and Spectranetics Dominate the European Coronary Atherectomy and OCT Markets, Reports iData

Boston Scientific, St. Jude, and Spectranetics Dominate the European Coronary
Atherectomy and OCT Markets, Reports iData Research

High growth in smaller segments of the European interventional cardiology
market contributes to continued increase and development of the total market.

VANCOUVER, British Columbia, June 27, 2013 (GLOBE NEWSWIRE) -- via PRWEB -
Heart disease is a major cause of death and hospitalization in several
European countries, as observed in a 2012 OECD (Organisation for Economic
Co-Operation and Development) study. While previous methods for treating
obstructed coronary arteries involved open-chest surgery, this is no longer
the case today as coronary angioplasty techniques have transformed the
treatment of ischemic heart disease. Although the boom years of angioplasty
procedures may have subsided, they still promise to maintain their penetration
rates as a large middle-aged cohort continues to age and enter a high risk
category for coronary disease and myocardial infarction.

According to iData Research, the leading authority in global market research,
the European interventional cardiology market is valued at almost $2 billion.
"While the greatest share of the total market belongs to coronary stents, used
for treatment of coronary heart disease, it is the coronary atherectomy device
and optical coherence tomography (OCT) catheter markets that represent the
greatest growth," explains Dr. Kamran Zamanian, CEO of iData Research. An
atherectomy is a procedure by which plaque is removed from the arteries and
normal blood flow is established. Atherectomy devices are used when there is
calcification in the arteries and the blood flow cannot be restored through
the use of grafts. Germany represented the largest market for these devices in
Europe in 2012, nearly twice the size of the next largest market in terms of
unit sales. The same is true for the OCT catheter market. While OCT has been
used for a number of years in other medical fields, such as in ophthalmology,
it has only been applied to cardiology since 2006 in Japan and Europe.

Regarding major competitors, Boston Scientific led the overall European
interventional cardiology market in 2012, with Abbott, Medtronic, and Cordis
following closely. The company was at the forefront of the drug-eluting stent,
coronary embolic protection device, PTCA balloon catheter, IVUS catheter, and
atherectomy device markets, where they secured the greatest market share. The
only other competitor in the atherectomy device market was Spectranetics, but
the two might soon be sharing space with other competitors involved in
peripheral atherectomy such as Cardiovascular Systems Inc. (CSI), Covidien,
Pathway Medical Technologies and Minnow Medical. The OCT catheter market also
presented limited competition as St. Jude Medical accounted for 100% of the
market in 2012 through sales of their C7-XR™ OCT intravascular imaging system
and C7 Dragonfly™ imaging catheter, which were the only OCT devices approved
for sale in Europe in 2012. Other companies that are looking to enter the
coronary OCT systems market are Volcano Therapeutics, Terumo, Carl Zeiss
Meditec, and Heidelberg Engineering.

A synopsis for each market intelligence publication in the global series on
the Markets for Interventional Cardiology covering the U.S., Japan, Brazil, as
well as 15 European countries is available here. The full series provides a
comprehensive analysis including procedure numbers, units sold, market value,
forecasts, as well as a detailed competitive market shares and analysis of
major players' success strategies in each market and segment. The reports also
cover markets for: coronary stents, percutaneous transluminal coronary
angioplasty balloon catheters, interventional coronary guidewires, coronary
introducer sheaths, coronary embolic protection devices, diagnostic coronary
catheters, fractional flow reserve guidewires, coronary vascular closure
devices, intravascular ultrasound catheters, and vulnerable plaque devices.

About iData Research

iData Research is an international market research and consulting group
focused on providing market intelligence for medical device and pharmaceutical
companies. iData covers research in areas such as: vascular access,
interventional cardiology, peripheral vascular access, infusion therapy,
cardiac rhythm management, cardiac surgery, patient monitoring, and diabetes
monitoring, treatment, and drug delivery.

This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit
http://www.prweb.com/releases/2013/6/prweb10877008.htm

CONTACT: iData Research
         Olivia Fellows
         olivia@idataresearch.net
         604-266-6933
 
Press spacebar to pause and continue. Press esc to stop.